日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer

循环肿瘤反应性T细胞的表型可预测非小细胞肺癌对免疫检查点抑制剂的反应

Ito, Katsuhiro; Iida, Kei; Hirano, Tomoko; Man Long Leong, Merrin; Morii, Kenji; Menju, Toshi; Date, Hiroshi; Ozasa, Hiroaki; Yoshida, Hironori; Hirai, Toyohiro; Kawashima, Shusuke; Aoyama, Kazuhiro; Saeki, Yuka; Inozume, Takashi; Kobayashi, Takashi; Chamoto, Kenji; Yaguchi, Tomonori

Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions

嵌合的MHC I类和II类限制性非自身表位可拓宽抗肿瘤T细胞反应

Rongsheng Zhang,Rong Ma,Merrin M L Leong,Ian R Watson,Kei Iida,Tomonori Yaguchi,Fumihiko Matsuda,Tasuku Honjo,Kenji Chamoto

Tumor-induced radial vascular patterning in the chick chorioallantoic membrane

鸡胚绒毛尿囊膜中肿瘤诱导的放射状血管模式形成

Chamoto, Kenji; Pan, Jennifer M; Cho, Jae M; Khalil, Hassan A; Ackermann, Maximilian; Mentzer, Steven J

Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderly

与年龄相关的免疫状态和PD-1阻断:老年人的机制和策略

Yaguchi, Tomonori; Chamoto, Kenji; Honjo, Tasuku

ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis

ICOS+CD4+ T 细胞与抗 PD-1 疗法诱发的肺部病变高度相关。

Mari Yokoi ,Kosaku Murakami ,Tomonori Yaguchi ,Kenji Chamoto ,Hiroaki Ozasa ,Hironori Yoshida ,Mirei Shirakashi ,Katsuhiro Ito ,Yoshihiro Komohara ,Yukio Fujiwara ,Hiromu Yano ,Tatsuya Ogimoto ,Daiki Hira ,Tomohiro Terada ,Toyohiro Hirai ,Hirotake Tsukamoto

Mathematical mechanistic model representing the cancer immunity cycle under radiation effects

描述辐射效应下癌症免疫循环的数学机制模型

Takayanagi, Taisuke; Miyazaki, Koichi; Yamasaki, Kana; Yamada, Takahiro; Ebina, Futaro; Kanehira, Takahiro; Onodera, Yasuhito; Kobashi, Keiji; Taguchi, Hiroshi; Yasuda, Koichi; Katoh, Norio; Hashimoto, Takayuki; Aoyama, Hidefumi; Shirato, Hiroki; Chamoto, Kenji

Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy

光动力疗法联合他拉泊芬对T细胞的有益作用可增强癌症免疫治疗

Ezzaldeen, Ehab M; Yaguchi, Tomonori; Imagawa, Ryotaro; Soltan, Mohamed A; Hirata, Akira; Murakami, Kosaku; Tsukamoto, Hirotake; Muto, Manabu; Honjo, Tasuku; Chamoto, Kenji

Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling

PD-1信号通路缺陷的人类和小鼠的记忆B细胞发育和抗体反应受损

Masato Ogishi ,Koji Kitaoka ,Kim L Good-Jacobson ,Darawan Rinchai ,Baihao Zhang ,Jun Wang ,Vincent Gies ,Geetha Rao ,Tina Nguyen ,Danielle T Avery ,Taushif Khan ,Megan E Smithmyer ,Joseph Mackie ,Rui Yang ,Andrés Augusto Arias ,Takaki Asano ,Khoren Ponsin ,Matthieu Chaldebas ,Peng Zhang ,Jessica N Peel ,Jonathan Bohlen ,Romain Lévy ,Simon J Pelham ,Wei-Te Lei ,Ji Eun Han ,Iris Fagniez ,Maya Chrabieh ,Candice Laine ,David Langlais ,Conor Gruber ,Fatima Al Ali ,Mahbuba Rahman ,Caner Aytekin ,Basilin Benson ,Matthew J Dufort ,Clara Domingo-Vila ,Kunihiko Moriya ,Mark Shlomchik ,Gulbu Uzel ,Paul E Gray ,Daniel Suan ,Kahn Preece ,Ignatius Chua ,Satoshi Okada ,Shunsuke Chikuma ,Hiroshi Kiyonari ,Timothy I Tree ,Dusan Bogunovic ,Philippe Gros ,Nico Marr ,Cate Speake ,Richard A Oram ,Vivien Béziat ,Jacinta Bustamante ,Laurent Abel ,Bertrand Boisson ,Anne-Sophie Korganow ,Cindy S Ma ,Matthew B Johnson ,Kenji Chamoto ,Stéphanie Boisson-Dupuis ,Tasuku Honjo ,Jean-Laurent Casanova ,Stuart G Tangye

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade

可溶性免疫检查点因子反映了抗肿瘤免疫的耗竭以及对PD-1阻断的反应。

Hayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Goto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku

The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study

PD-1和PD-L1可溶性形式的联合检测作为晚期癌症患者PD-1阻断治疗的预测标志物:一项多中心回顾性研究

Kurosaki, Takashi; Chamoto, Kenji; Suzuki, Shinichiro; Kanemura, Hiroaki; Mitani, Seiichiro; Tanaka, Kaoru; Kawakami, Hisato; Kishimoto, Yo; Haku, Yasuharu; Ito, Katsuhiro; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Chiba, Yasutaka; Yaguchi, Tomonori; Omori, Koichi; Kobayashi, Takashi; Nakagawa, Kazuhiko; Honjo, Tasuku; Hayashi, Hidetoshi